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httpcense.Abstract Thoracic epidural anesthesia (TEA) with local anesthetics during OLV is increasingly
being combined with general anesthesia (GA) in our clinical practice for thoracic surgery. A com-
bination of TEA with GA might maximize the beneﬁts of each form of anesthesia. Furthermore,
epidural anesthesia and postoperative epidural analgesia may improve outcome in high-risk
patients.
Aim of the study: The present study was designed to compare the effects of thoracic epidural
anesthesia on oxygenation and pulmonary venous admixture (Qs/Qt), when combined with isoﬂu-
rane or propofol anesthesia, during one lung ventilation and to compare also between the effects of
propofol with isoﬂurane on oxygenation and pulmonary venous admixture (Qs/Qt), during one
lung ventilation.
Methods: This study was carried out on 60 patients, (ASA classiﬁcation I–II–III) in Tanta Uni-
versity Hospitals, scheduled for thoracotomies for pulmonary resections in the lateral decubitus
position and one-lung ventilation. The patients were randomized into one of four groups, 15
patients in each group: Group I: propofol group (TIVA group), Group II: propofol combined with
thoracic epidural anesthesia (TIVA-TEA group), Group III: isoﬂurane group (ISO group) and
Group IV: isoﬂurane combined with thoracic epidural. The trachea was intubated with a double-
lumen tube and its position was conﬁrmed with auscultation. Anesthesia was maintained with pro-
pofol at continuous infusion in (Group I and Group II), and with isoﬂurane in (Group III and
Group IV) and with increments of fentanyl and vecuronium. PaO2, PaCO2, SaO2, PvO2, SvO2
and Hb, as well as the hemodynamic variables (HR and MAP) were measured. A right atrial blood
sample was used to calculate the pulmonary venous admixture (Qs/Qt). In epidural groups (Group
II and Group IV) a 10-ml bolus of a solution of bupivacaine 0.1%+ 0.1 mg/ml morphine in salinee Egyptian Society of Chest
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478 R.S. Abdelrahmanwas administered at least 30 min before the induction, followed by a 7 ml/h infusion of the same
solution during the operation. In the other two groups (Group III and Group IV), no medication
was applied via the epidural catheter in the preoperative and the intraoperative period. After pre-
oxygenation, anesthesia was induced with fentanyl 3 lg/kg and propofol 2 mg/kg; tracheal intuba-
tion was facilitated with vecuronium 0.1 mg/kg.
Results: As regards PaO2, it was signiﬁcantly higher in Group I and Group II (propofol groups)
than Group III and Group IV (isoﬂurane), in contrary, no signiﬁcant effect of TEA (between
Group I and Group II) nor between (Group III and Group IV) on PaO2. However; PaO2 signif-
icantly decreased during OLV in all groups. As regards Qs/Qt, it was signiﬁcantly lower in Group
I and Group II (propofol groups) than Group III and Group IV (isoﬂurane), in contrary, no sig-
niﬁcant effect of TEA (between GI and GII) nor between (GIII and GIV) on Qs/Qt. However; Qs/
Qt signiﬁcantly increased during OLV in all groups.
Conclusions: The administration of thoracic epidural anesthesia, either combined with propofol
or isoﬂurane, was not associated with a relevant impairment of oxygenation during OLV. Therefore
Pre-emptive analgesia via an epidural thoracic catheter can be used safely as a standard in lung sur-
gery, decreasing the anesthesia requirements when combined with GA, maximizing the beneﬁts of
each form of anesthesia and improving the outcome in patients with cardiopulmonary diseases,
hence it was found that it has no effect on oxygenation during OLV, and it is associated with stable
hemodynamics.
ª 2012 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
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During one-lung ventilation (OLV) with patients in the lateral
decubitus position, there is a potential risk of considerable
intrapulmonary shunting of deoxygenated pulmonary arterial
blood, which may result in hypoxemia. The consequences of
an increase in pulmonary vascular resistance (PVR) in the non-
dependent (non-ventilated) lung are to redistribute blood ﬂow
to the ventilated dependent lung, thereby preventing the arte-
rial oxygen tension (Pao2) from excessively decreasing. This in-
crease in nondependent lung pulmonary vascular resistance is
predominantly due to hypoxic pulmonary vasoconstriction
(HPV) [1]. After thoracotomies, analgesia through a thoracic
epidural catheter is considered as the most preferable method
to treat the acute and chronic pain [2,3]. Thoracic epidural
anesthesia (TEA) with local anesthetics during OLV is increas-
ingly being combined with general anesthesia (GA) in our clin-
ical practice for thoracic surgery. A combination of TEA with
GA might maximize the beneﬁts of each form of anesthesia [4].
Furthermore, epidural anesthesia and postoperative epidural
analgesia may improve outcome in high-risk patients [5]. Po-
tential disadvantages include the time required to establish epi-
dural anesthesia, intravascular ﬂuid administration needed to
avoid hypotension, and the potential for technical complica-
tions, such as epidural hematoma.
The effect of intraoperative TEA with local anesthetics on
HPV during thoracic surgery and OLV is unclear. The pul-
monary vasculature is innervated by the autonomic nervous
system, and the sympathetic tone is dominant in the pulmon-
ary circulation relative to parasympathetic activity.
Theoretically, a TEA induced sympathyectomy might attenu-
ate HPV [6]. Aim of this study was to compare the effects of tho-
racic epidural anesthesia on oxygenation and pulmonary venous
admixture (Qs/Qt), when combined with isoﬂurane or propofol
anesthesia, during one lung ventilation and to compare also be-
tween the effects of propofol with isoﬂurane on oxygenation and
pulmonaryvenous admixture (Qs/Qt), duringone lungventilation.Patients and methods
This study was carried out on 60 patients, aged 20 to 60 years
(ASA classiﬁcation I–II–I) in Tanta University Hospitals,
scheduled for thoracotomies for pulmonary resections in the
lateral decubitus position and one-lung ventilation.
Exclusion criteria
Patient refusal, uncooperative patients, hypovolaemia and
abnormal clotting parameters cardiac and/or vascular disease,
forced vital capacity (FVC) <50% predicted and/or, forced
expiratory volume 1s (FEV1) <50% and renal insufﬁciency
or liver dysfunction.
Intraoperative exclusion criteria
Hypoxia (SpO2 < 90%) that necessitate (CPAP to indepen-
dent lung).
Preoperative assessment
n History and clinical examination.
n Laboratory investigation, electrocardiogram, chest X-ray.
Preoperative pulmonary function tests including measure-
ments of: forced vital capacity (FVC), and forced expira-
tory volume in 1 s (FEV1). These values as a percentage
of predicted values (FVC%, FEV1%). Arterial blood gas
analysis on the evening before surgery.Groups of patients
The patients were randomized into one of four groups, 15 pa-
tients in each group:
n Group I: propofol group (TIVA group).
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sia (TIVA-TEA group).
n Group III: isoﬂurane group (ISO group).
n Group IV: isoﬂurane combined with thoracic epidural anes-
thesia (ISO-TEA group).
Anesthetic technique: Before induction of anesthesia, hemo-
dynamic monitoring was established with a radial artery cath-
eter contralateral to the operated side for invasive blood
pressure monitoring, arterial blood gas sampling and hemoglo-
bin determinations and a central venous catheter was inserted
under local anesthesia via the subclavian vein or internal jug-
ular vein of the operative side.
In all patients, an 18-gauge epidural catheter was inserted
through the T7–8 intervertebral space pre-operatively by a
mid-line approach. In epidural groups (Group II and Group
IV) a 10-ml bolus of a solution of bupivacaine 0.1%+
0.1 mg/ml morphine in saline was administered at least 30 min
before the induction, followed by a 7 ml/h infusion of the same
solution during the operation.
In the other two groups (Group III and Group IV), no
medication was applied via the epidural catheter in the preop-
erative and the intraoperative period.
After pre-oxygenation, anesthesia was induced with fenta-
nyl 3 lg/kg and propofol 2 mg/kg; tracheal intubation was
facilitated with vecuronium 0.1 mg/kg the trachea was intu-
bated with a double-lumen tube and its position was conﬁrmed
with auscultation.
Anesthesia was maintained with propofol at continuous
infusion in (Group I and Group II), and with isoﬂurane in
(Group III and Group IV) and with increments of fentanyl
and vecuronium.
The followings were measured:
PaO2, PaCO2, SaO2, PvO2, SvO2 and Hb, as well as the
hemodynamic variables (HR and MAP). A right atrial blood
sample was used to calculate the pulmonary venous admixture
(Qs/Qt) by the following equation:
Qs=Qt ¼ ðCcO2 CaO2Þ=ðCcO2 CvO2Þ  100:Times of measurements
n T1. Before induction of anesthesia while the patients are
supine and breathing room air.
n T2. During two-lung ventilation 10 min after surgical open-
ing of the chest, while patients are in the lateral decubitus
position.
n T3. During one-lung ventilation 10 min after collapse of the
nondependent lung, in the lateral decubitus position.
n T4. Rechanging to two-lung ventilation, lateral decubitus
position.
n T5. During two-lung ventilation, supine position.
n T6. After extubation while the patients are supine and
breathing 2 L/min oxygen per mask.Statistical analysis
Statistical presentation and analysis of the present study was
conducted, using SPSS statistics (V.17.0; SPSS Inc., Chicago,
IL, USA).Results
This study was carried out on 60 patients, aged 20 to 60 years
(ASA classiﬁcation I–II–I) in Tanta University Hospitals,
scheduled for thoracotomies for pulmonary resections in the
lateral decubitus position and one-lung ventilation.
Comparison between groups shows no signiﬁcant difference
(p> 0.05) in the demographic data, preoperative pulmonary
function tests (PFT), hemoglobin (Hb), and arterial blood
gases (ABG). Also type, side and duration of surgery were sta-
tistically comparable in between groups (p> 0.05).
On studying MAP between different groups in different
times, there was insigniﬁcant effect of time (f= 1.641,
P= 0.236), group (f= 1.389, P= 0.294) and time · group
interaction (f= 4.624, P= 0.585). As regard HR between dif-
ferent groups in different times, there was insigniﬁcant effect of
time (f= 0.295, P= 0.905), group (f= 3.117, P= 0.066) and
time · group interaction (f= 4.232, P= 0.054). There was
insigniﬁcant effect of time (f= 2.002, P= 0.164), group
(f= 0.180, P= 0.908) and time · group interaction
(f= 3.534, P= 0.125) on Hb level between different groups.
On studying PaO2 between different times in different
groups, two-way repeated measure ANOVA followed by post
hoc multiple comparison (Tukey test) was used to analyze the
effect of time, group and time · group interaction, There was
a signiﬁcant effect of time (P< 0.0001, F= 58.19), in the four
groups. PaO2 signiﬁcantly increased from T1 to T2
(P< 0.0001, F= 105.38), then signiﬁcantly decreased in
(OLV) T3 vs. T2 (P< 0.0001, F= 146.3), then signiﬁcantly in-
creased in T4 vs. T3 (OLV) (P< 0.0001, F= 231.3), also in T5
vs. T4 (P< 0.0001, F= 29.13), and ﬁnally signiﬁcantly de-
creased from T5 to T6 (P< 0.0001, F= 120). Also, on com-
paring PaO2 within the different groups, there was signiﬁcant
effect of groups (P= 0.046, F= 3.58). During OLV (T3) there
was signiﬁcant change in Pao2 in between different groups
(P= 0.002, F= 5.65), in contrary no signiﬁcant change was
found in PaO2 inbetween groups in other measurement times
(p> 0.05) Using post hoc (Tukey test), it was found that there
was a signiﬁcant reduction (P< 0.05) in Pao2 during OLV
(T3) in Group III (ISO) and Group IV (ISO-TEA) when com-
pared with Group I (TIVA). Also there was a signiﬁcant de-
crease (P< 0.05) in PaO2 during OLV (T3) in Group IV
(ISO-TEA) when compared with Group II (ISO-TEA). In con-
trary there was no signiﬁcant difference (p> 0.05) in Pao2 nei-
ther between Group I and Group II nor between Group III and
Group IV and nor between Group II and Group III. On com-
paring PaO2 within the different groups during (T2, T4 and T5)
there was insigniﬁcant (p> 0.05) increase in PaO2 in Group I
and Group II when compared with Group III and Group IV,
also insigniﬁcant difference in PaO2 was found in different
groups during(T1 and T6).
In contrary to time and group effect, there was no signiﬁ-
cant interaction of time · group (P= 0.066, F= 14.64) (Ta-
ble 1 and Fig. 1).
On studying SaO2 between different times in different
groups, there was a signiﬁcant effect of time (p< 0.0001,
f= 2231.52), in the four groups, PaO2 signiﬁcantly increased
from T1 to T2 (p< 0.0001, f= 1959.75), then signiﬁcantly de-
creased in (OLV) T3 vs. T2 (p< 0.001, f= 20.21), then signif-
icantly increased in T4 vs. T3 (OLV) (p= 0.001, f= 20.14),
also in T5 vs. T4 (p= 0.02, f= 6.88), and ﬁnally signiﬁcantly
Table 1 PaO2 in T3 (OLV),comparison between groups using
Tukey test.
Tukey test P
T3 (OLV) GI (propofol) GII 0.882
GIII 0.018
GIV 0.007
GII (prop + TEA) GI 0.882
GIII 0.108
GIV 0.048
GIII (ISO) GI 0.018
GII 0.108
GIV 0.985
GIV (ISO+ TEA) GI 0.007
GII 0.048
GIII 0.985
Figure 1 Time course of PaO2 in different groups.
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comparing SaO2 within the different groups, there was no sig-
niﬁcant effect of groups (p= 0.646, f= 0.569). No signiﬁcant
change was found in SaO2 in between groups in different mea-
surement times (p> 0.05). Also, there was no signiﬁcant inter-
action of time · group (p> 0.05).
As regard PaCO2 between different groups in different
times there was insigniﬁcant effect of time (f= 1.581,
P= 0.251), group (f= 0.728, P= 0.555) and time · group
interaction (f= 2.638, P= 0.144).
On studying PvO2 between different times in different
groups there was a signiﬁcant effect of time (p< 0.0001,
f= 1082.3), in the four groups, PvO2 signiﬁcantly increased
from T1 to T2 (p< 0.0001, f= 1494.82), then insigniﬁcantly
decreased in (OLV) T3 vs. T2 (p= 0.06, f= 27.29), then insig-
niﬁcantly increased in T4 vs. T3 (OLV) (p = 0.07, f= 25.14),
also in T5 vs. T4 (p= 0.054, f= 18.9), and ﬁnally signiﬁcantly
decreased from T5 to T6 (p< 0.0001, f= 1389.48). While, on
comparing PvO2 within the different groups, there was no sig-
niﬁcant effect of groups (p= 1.648, f= 0.231). No signiﬁcant
change was found in PvO2 in between groups in different mea-
surement times (p> 0.05). Also, there was no signiﬁcant inter-
action of time · group (p> 0.05) (Table 2).
On studying SvO2 between different times in different
groups, there was a signiﬁcant effect of time (p< 0.0001,
f= 900.13), in the four groups, SvO2 signiﬁcantly increasedfrom T1 to T2 (p< 0.0001, f= 3133.1), then insigniﬁcantly
decreased in (OLV) T3 vs. T2 (p= 0.056, f= 3.29), then insig-
niﬁcantly increased in T4 vs. T3 (OLV) (p= 0.06, f= 3.14),
also in T5 vs. T4 (p= 0.07, f= 2.9), and ﬁnally signiﬁcantly
decreased from T5 to T6 (p< 0.0001, f= 1337.46). While,
on comparing SvO2 within the different groups, there was
no signiﬁcant effect of groups (p= 0.893, f= 0.202). No sig-
niﬁcant change was found in SvO2 in between groups in differ-
ent measurement times (p> 0.05). Also, there was no
signiﬁcant interaction of time · group (p> 0.05) (Fig. 2).
Qs/Qt between different times in different groups, there was
a signiﬁcant effect of time (p< 0.0001, f= 58.81), in the four
groups, PaO2 insigniﬁcantly increased from T1 to T2
(p= 0.330, f= 1.02), then signiﬁcantly increased in (OLV)
T3 vs. T2 (p< 0.0001, f= 91.5), then signiﬁcantly decreased
in T4 vs. T3 (OLV) (p< 0.0001, f= 105.24), but insigniﬁ-
cantly decreased in T5 vs. T4 (p= 0.06, f= 6.13), and ﬁnally
insigniﬁcantly decreased from T5 to T6 (p= 0.662, f= 0.199).
Also, on comparing Qs/Qt within the different groups, there
was signiﬁcant effect of groups (p= 0.043, f= 3.7). During
OLV (T3) there was signiﬁcant change in PaO2 in between dif-
ferent groups (p= 0.003, f= 5.2), in contrary no signiﬁcant
change was found in Qs/Qt in between groups in other mea-
surement times (p> 0.05) Using post hoc (Tukey test), during
OLV (T3), it was found that there was a signiﬁcant increase
(P< 0.05) in Qs/Qt in Group III and Group IV when com-
pared with Group I. Also there was a signiﬁcant increase
(P< 0.05) in Qs/Qt during OLV (T3) in Group IV when com-
pared with Group II. In contrary there was no signiﬁcant dif-
ference (p> 0.05) in Pao2 neither between Group I and
Group II nor between Group III and Group IV and nor be-
tween Group II and Group III. On comparing Qs/Qt within
the different groups (Fig. 3) during (T2, T4 and T5) there
was insigniﬁcant (p> 0.05) decrease in Qs/Qt in Group I
and Group II when compared with Group III and Group
IV, also insigniﬁcant difference in Qs/Qt was found in different
groups during (T1 and T6). In contrary to time and group ef-
fect, there was no signiﬁcant interaction of time · group
(P= 0.072, f= 11.64).
Discussion
The persistent perfusion in the non-ventilated operative lung
during one-lung ventilation (OLV) in patients undergoing tho-
racic surgery increases intrapulmonary shunt and decreases
systemic arterial oxygenation.
A physiologic defense mechanism termed ‘‘hypoxic pul-
monary vasoconstriction (HPV)’’, redistributes pulmonary
blood ﬂow to the better ventilated, dependent lung in order
to maintain systemic oxygenation.
HPV is themost important factor to optimize pulmonary gas
exchange during OLV [7]. Other less important factors that can
inﬂuence the shunt include: changes in pulmonary vascular
resistance, cardiac output and double-lumen tube malposition.
The choice of anesthetic technique for OLV should take into
consideration the effects on oxygenation and therefore onHPV.
A large number of factors (anesthetic agents, acid/base
imbalance, temperature changes, lung manipulation, vasodila-
tors, etc.) can be involved in the magnitude of HPV in the non-
ventilated lung. Anesthetic regimens used for thoracic surgery
include total-IV anesthesia (TIVA), inhalational anesthesia
Table 2 PvO2 in different measurement times in different groups.
Group time GI (Propofol) GII (Prop + TEA) GIII (ISO) GIV (ISO+ TEA) F P
T1 (baseline) 40.6 ± 2.83 39.75 ± 2.95 40.71 ± 3.26 39.74 ± 1.99 0.537 0.659
T2 (after induction) 51.33 ± 3.29 50.51 ± 3.77 50.95 ± 2.49 50.71 ± 2.42 0.201 0.896
T3 (OLV) 49.5 ± 3.3 48.08 ± 4.29 50.01 ± 2.43 50.68 ± 4.74 1.951 0.132
T4 (TLV/lat) 50.8 ± 2.58 50.59 ± 3.37 50.59 ± 2.34 50.85 ± 2.42 0.156 0.925
T5 (TLV/supine) 51.27 ± 2.1 51 ± 2.2 51.35 ± 2.56 50.9 ± 2.4 0.443 0.723
T6 (postextubation) 40.71 ± 2.5 40.99 ± 1.63 41.27 ± 2.12 40.24 ± 3.19 0.494 0.688
Figure 2 Time course of SvO2 (%) in different groups.
Figure 3 Time course of Qs/Qt(%) in different groups.
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(TEA) combined with either inhalational or intravenous anes-
thetic agents.
The choice of anesthetic technique for OLV should take
into consideration the effects on oxygenation and therefore
on HPV [8]. A large number of factors (anesthetic agents,
acid/base imbalance, temperature changes, lung manipulation,
vasodilators, etc.) can be involved in the magnitude of HPV in
the non-ventilated lung.
Our results have shown that propofol improved oxygena-
tion and shunt fraction during one-lung ventilation compared
with volatile anesthetics.In agreement with our results, an animal study by Schwarz-
kopf et al. [9] comparing the effects of propofol, isoﬂurane and
desﬂurane on oxygenation and shunt fraction, showed that
Pao2 decreased during isoﬂurane and desﬂurane as compared
with propofol whereas shunt fraction remained comparable.
Similar results was obtained in a previous in vivo study by
Abe et al. [10], whereas during one-lung ventilation, the arte-
rial partial pressure of oxygen values with propofol were great-
er than those with isoﬂurane and sevoﬂurane, and shunt
fraction values with propofol were lower than those with both
volatile anesthetics. However the experimental sequence was
such the volatile agents always preceded the propofol. The
reduction in shunt fraction may be because the propofol was
always given at a later stage of surgery and after long period
of OLV. The timing of measurements and their relation to
the stage of the surgical procedure is important since surgical
trauma can temporarily inhibit HPV [11].
In contrary to our result, a study by Pruszkowski et al. [12]
comparing the use of propofol vs. the use of another inhala-
tional agent (sevoﬂurane) during one lung ventilation con-
cluded that sevoﬂurane and propofol had similar effect on
PaO2 during OLV when their administration is titrated to
maintain BIS between 40 and60.
This controversy can be explained by the fact that haloge-
nated volatile anesthetics produce concomitant direct and indi-
rect effects on oxygenation. Direct effect is demonstrated in
some studies: a large inhaled agent concentration caused in-
creased inhibition of HPV [12]. Indirect effect is observed when
cardiac output is decreased, improving the effect of HPV on
oxygenation.
Thoracotomy is one of the most painful surgical procedures
followed by intense, acute, and chronic pain associated with
postthoracotomy [3,13,14]. After thoracotomies, analgesia
via an epidural thoracic catheter is an effective and important
method of analgesia in the immediate postoperative period
[15]. Initiation of epidural medication before the noxious stim-
ulus is associated with improved analgesia [16]. Also, the use of
thoracic epidural anesthesia (TEA) combined with general
anesthesia can contribute to facilitate the fast-track approach
for patients undergoing lung surgery [17]. It results in better
pain control and less respiratory depression after surgery as
compared to the use of intravenous (I.V.) opioids [18]. A re-
duced incidence of pulmonary morbidity also has been re-
ported [5,19,20].
So, TEA can be recommended as a standard in lung surgery
[21].However, during the operation, TEAwith epiduralmedica-
tions may impair oxygenation during one-lung ventilation
(OLV), which is an important challenge of thoracic anesthesia
[22]. As a result of the fact that the pulmonary vasculature is
innervated by the autonomic nervous system, hypoxic
482 R.S. Abdelrahmanpulmonary vasoconstriction (HPV) may be inﬂuenced by sym-
pathetic neural blockade, thereby altering shunt fraction (Qs/
Qt) and arterial oxygenation during OLV. Experimental and
clinical studies investigating the effects of TEA on oxygenation
and HPV showed contradictory results: oxygenation was found
to be suppressed [1], unaffected [23,24], or even enhanced [7,25].
Our study have shown that combining TEA with any tech-
nique of general anesthesia either TIVA with propofol or com-
bined with inhalational anesthesia does not further impair
oxygenation or increase shunt fraction.
In contrary with our results, Garutti et al. [1] observed
higher shunt fractions and lower Pao2 values during one-lung
ventilation in a TEA+ TIVA (propofol + bupivacaine)
group compared with a TIVA (propofol) group in patients
undergoing thoracotomy.
They concluded that TEA could not be recommended for
thoracic surgery requiring one-lung ventilation. However, in
this study high concentration of bupivacaine was used (bupiva-
cine 0.5% followed by infusion of bupivacaine 0.375% 6–8 ml/
h) wich results in hpotension in 50% of patient in the TEA+
TIVA group with subsequent ephedrine injection, which may
inﬂuenced the results.
In our study we used a relatively weaker local anesthetic
solution (0.1% bupivacaine) compared with other studies.
However, the efﬁcacy of this epidural regimen (bupivacaine
0.1%) in acute and chronic postthoracotomy pain has been
shown in previous studies [26]. In a very recent study, Xu
et al. [27] studying the effect of thoracic epidural anesthesia
with different concentrations of ropivacaine on arterial oxygen-
ation during one lung ventilation have shown that a decrease in
oxygenation during OLV occurred only at the highest dose of
epidural local anesthetic, and not at lower doses.
Several studies had used opioids rather than local anesthet-
ics, and studied their effects on oxygenation and shunt fraction
during OLV. Chow et al. compared the effects of an I.V. rem-
ifentanil infusion and epidural bupivacaine 0.5%, 0.1–0.2 ml/
kg via the epidural catheter, during each administration, there
was no signiﬁcant difference in PaO2 and Qs/Qt [28].
In a newer study, Garutti et al. investigated the effects of
epidural meperidine, and found that epidural meperidine
2 mg/kg had not resulted in impairment in oxygenation [25].
The range of depressant effects generated by high epidural
blockade can be quite broad depending on the extent of spinal
segment deafferentation. It was reported that block of T1–T4
results in deafferentation of cardiac sympathetic ﬁbers result-
ing in loss of the chronotropic and ionotropic drive to the
myocardium [29].
In our study the thoracic epidural was inserted at the mid-
thoracic region, thus no cardio depression, also we used a rel-
atively weaker local anesthetic solution (0.1% bupivacaine)
compared with other studies resulting in minimal effects on
arterial pressure.
Conclusion
The administration of thoracic epidural anesthesia, either com-
bined with propofol or isoﬂurane, was not associated with a
relevant impairment of oxygenation during OLV. Therefore
pre-emptive analgesia via an epidural thoracic catheter can
be used safely as a standard in lung surgery, decreasing the
anesthesia form of anesthesia and improving the outcome inpatients with cardiopulmonary diseases, hence it was found
that it has no effect on oxygenation during OLV, and it is asso-
ciated with stable hemodynamic.
Recommendation
Thoracic epidural anesthesia can be used as a standard in lung
surgery. Volatile anesthetic are not the preferred anesthetic
agent during one lung ventilation procedures as they inhibit
hypoxic pulmonary vasoconstriction decreasing arterial oxy-
genation and increasing shunt fraction. Further studies should
be done comparing the effect of TEA with different local anes-
thetic concentration on oxygenation, shunt fraction during
OLV and on hemodynamic parameters. Further studies should
be done to compare the effect of isoﬂurane and propofol on
hypoxic pulmonary vasoconstriction using (BIS) as a monitor
of the anesthetic depth, and not by using a predetermined
doses which may lead to higher drug administration than clin-
ically necessary, thus affecting the comparison.Reference
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